Intrinsic value of Eastman Chemical - EMN

Previous Close

$97.77

  Intrinsic Value

$72.57

stock screener

  Rating & Target

sell

-26%

Previous close

$97.77

 
Intrinsic value

$72.57

 
Up/down potential

-26%

 
Rating

sell

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of EMN stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -6.63
  7.80
  7.52
  7.27
  7.04
  6.84
  6.65
  6.49
  6.34
  6.21
  6.08
  5.98
  5.88
  5.79
  5.71
  5.64
  5.58
  5.52
  5.47
  5.42
  5.38
  5.34
  5.31
  5.28
  5.25
  5.22
  5.20
  5.18
  5.16
  5.15
  5.13
Revenue, $m
  9,008
  9,711
  10,441
  11,200
  11,988
  12,808
  13,660
  14,546
  15,469
  16,428
  17,428
  18,470
  19,555
  20,688
  21,869
  23,103
  24,391
  25,737
  27,144
  28,616
  30,155
  31,765
  33,451
  35,215
  37,064
  39,000
  41,028
  43,154
  45,382
  47,717
  50,166
Variable operating expenses, $m
 
  8,287
  8,877
  9,490
  10,126
  10,788
  11,476
  12,192
  12,937
  13,712
  14,519
  14,914
  15,790
  16,705
  17,659
  18,655
  19,695
  20,782
  21,918
  23,107
  24,349
  25,650
  27,011
  28,436
  29,928
  31,491
  33,129
  34,846
  36,645
  38,530
  40,508
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  7,710
  8,287
  8,877
  9,490
  10,126
  10,788
  11,476
  12,192
  12,937
  13,712
  14,519
  14,914
  15,790
  16,705
  17,659
  18,655
  19,695
  20,782
  21,918
  23,107
  24,349
  25,650
  27,011
  28,436
  29,928
  31,491
  33,129
  34,846
  36,645
  38,530
  40,508
Operating income, $m
  1,298
  1,423
  1,564
  1,710
  1,862
  2,020
  2,184
  2,354
  2,532
  2,717
  2,909
  3,556
  3,765
  3,983
  4,210
  4,448
  4,696
  4,955
  5,226
  5,509
  5,805
  6,116
  6,440
  6,780
  7,136
  7,508
  7,899
  8,308
  8,737
  9,187
  9,658
EBITDA, $m
  1,878
  2,266
  2,437
  2,614
  2,798
  2,989
  3,188
  3,395
  3,610
  3,834
  4,067
  4,310
  4,564
  4,828
  5,104
  5,392
  5,692
  6,006
  6,335
  6,678
  7,037
  7,413
  7,807
  8,218
  8,650
  9,102
  9,575
  10,071
  10,591
  11,136
  11,708
Interest expense (income), $m
  280
  263
  297
  332
  370
  408
  448
  490
  533
  578
  625
  674
  725
  778
  833
  891
  951
  1,014
  1,080
  1,149
  1,220
  1,296
  1,374
  1,457
  1,543
  1,633
  1,728
  1,827
  1,931
  2,039
  2,154
Earnings before tax, $m
  1,049
  1,160
  1,267
  1,378
  1,492
  1,612
  1,736
  1,865
  1,999
  2,139
  2,284
  2,882
  3,040
  3,205
  3,377
  3,557
  3,745
  3,941
  4,146
  4,361
  4,585
  4,820
  5,066
  5,323
  5,593
  5,875
  6,171
  6,481
  6,806
  7,147
  7,505
Tax expense, $m
  190
  313
  342
  372
  403
  435
  469
  503
  540
  577
  617
  778
  821
  865
  912
  960
  1,011
  1,064
  1,119
  1,177
  1,238
  1,301
  1,368
  1,437
  1,510
  1,586
  1,666
  1,750
  1,838
  1,930
  2,026
Net income, $m
  854
  847
  925
  1,006
  1,089
  1,176
  1,267
  1,361
  1,459
  1,561
  1,667
  2,104
  2,219
  2,340
  2,465
  2,597
  2,734
  2,877
  3,027
  3,183
  3,347
  3,519
  3,698
  3,886
  4,083
  4,289
  4,505
  4,731
  4,969
  5,217
  5,478

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  181
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  15,457
  16,459
  17,696
  18,983
  20,319
  21,708
  23,153
  24,655
  26,218
  27,845
  29,539
  31,304
  33,145
  35,064
  37,067
  39,157
  41,341
  43,623
  46,007
  48,501
  51,110
  53,839
  56,696
  59,687
  62,820
  66,101
  69,539
  73,142
  76,918
  80,876
  85,027
Adjusted assets (=assets-cash), $m
  15,276
  16,459
  17,696
  18,983
  20,319
  21,708
  23,153
  24,655
  26,218
  27,845
  29,539
  31,304
  33,145
  35,064
  37,067
  39,157
  41,341
  43,623
  46,007
  48,501
  51,110
  53,839
  56,696
  59,687
  62,820
  66,101
  69,539
  73,142
  76,918
  80,876
  85,027
Revenue / Adjusted assets
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
  0.590
Average production assets, $m
  7,763
  8,371
  9,000
  9,654
  10,334
  11,040
  11,775
  12,539
  13,334
  14,161
  15,023
  15,921
  16,857
  17,833
  18,851
  19,915
  21,025
  22,186
  23,398
  24,667
  25,993
  27,382
  28,834
  30,356
  31,949
  33,618
  35,366
  37,198
  39,119
  41,132
  43,243
Working capital, $m
  1,071
  1,262
  1,357
  1,456
  1,558
  1,665
  1,776
  1,891
  2,011
  2,136
  2,266
  2,401
  2,542
  2,689
  2,843
  3,003
  3,171
  3,346
  3,529
  3,720
  3,920
  4,129
  4,349
  4,578
  4,818
  5,070
  5,334
  5,610
  5,900
  6,203
  6,522
Total debt, $m
  6,594
  7,239
  8,110
  9,014
  9,953
  10,930
  11,945
  13,001
  14,100
  15,244
  16,435
  17,676
  18,970
  20,319
  21,727
  23,197
  24,732
  26,336
  28,012
  29,765
  31,599
  33,518
  35,526
  37,629
  39,831
  42,138
  44,555
  47,088
  49,742
  52,525
  55,443
Total liabilities, $m
  10,925
  11,570
  12,441
  13,345
  14,284
  15,261
  16,276
  17,332
  18,431
  19,575
  20,766
  22,007
  23,301
  24,650
  26,058
  27,528
  29,063
  30,667
  32,343
  34,096
  35,930
  37,849
  39,857
  41,960
  44,162
  46,469
  48,886
  51,419
  54,073
  56,856
  59,774
Total equity, $m
  4,532
  4,888
  5,256
  5,638
  6,035
  6,447
  6,876
  7,323
  7,787
  8,270
  8,773
  9,297
  9,844
  10,414
  11,009
  11,630
  12,278
  12,956
  13,664
  14,405
  15,180
  15,990
  16,839
  17,727
  18,657
  19,632
  20,653
  21,723
  22,845
  24,020
  25,253
Total liabilities and equity, $m
  15,457
  16,458
  17,697
  18,983
  20,319
  21,708
  23,152
  24,655
  26,218
  27,845
  29,539
  31,304
  33,145
  35,064
  37,067
  39,158
  41,341
  43,623
  46,007
  48,501
  51,110
  53,839
  56,696
  59,687
  62,819
  66,101
  69,539
  73,142
  76,918
  80,876
  85,027
Debt-to-equity ratio
  1.455
  1.480
  1.540
  1.600
  1.650
  1.700
  1.740
  1.780
  1.810
  1.840
  1.870
  1.900
  1.930
  1.950
  1.970
  1.990
  2.010
  2.030
  2.050
  2.070
  2.080
  2.100
  2.110
  2.120
  2.130
  2.150
  2.160
  2.170
  2.180
  2.190
  2.200
Adjusted equity ratio
  0.285
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297
  0.297

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  854
  847
  925
  1,006
  1,089
  1,176
  1,267
  1,361
  1,459
  1,561
  1,667
  2,104
  2,219
  2,340
  2,465
  2,597
  2,734
  2,877
  3,027
  3,183
  3,347
  3,519
  3,698
  3,886
  4,083
  4,289
  4,505
  4,731
  4,969
  5,217
  5,478
Depreciation, amort., depletion, $m
  580
  843
  873
  904
  936
  969
  1,004
  1,040
  1,078
  1,117
  1,158
  755
  799
  845
  893
  944
  996
  1,051
  1,109
  1,169
  1,232
  1,298
  1,367
  1,439
  1,514
  1,593
  1,676
  1,763
  1,854
  1,949
  2,049
Funds from operations, $m
  1,292
  1,690
  1,798
  1,909
  2,025
  2,146
  2,271
  2,402
  2,537
  2,678
  2,826
  2,858
  3,018
  3,185
  3,359
  3,540
  3,730
  3,928
  4,136
  4,352
  4,579
  4,816
  5,065
  5,325
  5,597
  5,882
  6,181
  6,494
  6,823
  7,167
  7,528
Change in working capital, $m
  -93
  91
  95
  99
  103
  107
  111
  115
  120
  125
  130
  135
  141
  147
  154
  160
  167
  175
  183
  191
  200
  209
  219
  229
  240
  252
  264
  276
  290
  304
  318
Cash from operations, $m
  1,385
  1,599
  1,703
  1,811
  1,923
  2,039
  2,160
  2,286
  2,417
  2,554
  2,696
  2,723
  2,877
  3,038
  3,205
  3,380
  3,563
  3,753
  3,953
  4,161
  4,379
  4,607
  4,845
  5,095
  5,357
  5,630
  5,917
  6,218
  6,533
  6,863
  7,209
Maintenance CAPEX, $m
  0
  -368
  -397
  -427
  -458
  -490
  -523
  -558
  -594
  -632
  -671
  -712
  -755
  -799
  -845
  -893
  -944
  -996
  -1,051
  -1,109
  -1,169
  -1,232
  -1,298
  -1,367
  -1,439
  -1,514
  -1,593
  -1,676
  -1,763
  -1,854
  -1,949
New CAPEX, $m
  -626
  -608
  -629
  -654
  -680
  -707
  -735
  -764
  -795
  -827
  -862
  -898
  -936
  -976
  -1,019
  -1,063
  -1,111
  -1,160
  -1,213
  -1,268
  -1,327
  -1,388
  -1,453
  -1,521
  -1,593
  -1,669
  -1,748
  -1,832
  -1,920
  -2,013
  -2,111
Cash from investing activities, $m
  -655
  -976
  -1,026
  -1,081
  -1,138
  -1,197
  -1,258
  -1,322
  -1,389
  -1,459
  -1,533
  -1,610
  -1,691
  -1,775
  -1,864
  -1,956
  -2,055
  -2,156
  -2,264
  -2,377
  -2,496
  -2,620
  -2,751
  -2,888
  -3,032
  -3,183
  -3,341
  -3,508
  -3,683
  -3,867
  -4,060
Free cash flow, $m
  730
  623
  677
  730
  785
  843
  903
  964
  1,028
  1,094
  1,163
  1,113
  1,187
  1,263
  1,342
  1,423
  1,508
  1,597
  1,688
  1,784
  1,883
  1,987
  2,095
  2,207
  2,325
  2,448
  2,576
  2,710
  2,850
  2,996
  3,149
Issuance/(repayment) of debt, $m
  -428
  826
  870
  904
  940
  977
  1,015
  1,056
  1,099
  1,144
  1,191
  1,241
  1,294
  1,349
  1,408
  1,470
  1,535
  1,604
  1,677
  1,753
  1,834
  1,919
  2,008
  2,103
  2,202
  2,307
  2,417
  2,533
  2,655
  2,783
  2,918
Issuance/(repurchase) of shares, $m
  -130
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -566
  826
  870
  904
  940
  977
  1,015
  1,056
  1,099
  1,144
  1,191
  1,241
  1,294
  1,349
  1,408
  1,470
  1,535
  1,604
  1,677
  1,753
  1,834
  1,919
  2,008
  2,103
  2,202
  2,307
  2,417
  2,533
  2,655
  2,783
  2,918
Total cash flow (excl. dividends), $m
  160
  1,449
  1,547
  1,634
  1,725
  1,820
  1,918
  2,020
  2,127
  2,238
  2,354
  2,354
  2,480
  2,612
  2,749
  2,893
  3,043
  3,201
  3,365
  3,537
  3,717
  3,906
  4,103
  4,310
  4,527
  4,754
  4,993
  5,242
  5,504
  5,779
  6,067
Retained Cash Flow (-), $m
  -591
  -356
  -368
  -382
  -397
  -413
  -429
  -446
  -464
  -483
  -503
  -524
  -547
  -570
  -595
  -621
  -649
  -678
  -708
  -741
  -775
  -811
  -849
  -888
  -930
  -975
  -1,021
  -1,070
  -1,122
  -1,176
  -1,233
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  1,093
  1,179
  1,252
  1,328
  1,407
  1,489
  1,574
  1,663
  1,755
  1,851
  1,830
  1,934
  2,042
  2,155
  2,272
  2,395
  2,523
  2,657
  2,796
  2,942
  3,095
  3,255
  3,422
  3,597
  3,780
  3,971
  4,172
  4,383
  4,603
  4,834
Discount rate, %
 
  8.40
  8.82
  9.26
  9.72
  10.21
  10.72
  11.26
  11.82
  12.41
  13.03
  13.68
  14.37
  15.09
  15.84
  16.63
  17.46
  18.34
  19.25
  20.22
  21.23
  22.29
  23.40
  24.57
  25.80
  27.09
  28.45
  29.87
  31.36
  32.93
  34.58
PV of cash for distribution, $m
 
  1,008
  996
  960
  916
  865
  808
  746
  680
  612
  544
  446
  386
  329
  275
  226
  182
  144
  112
  85
  63
  45
  32
  22
  15
  9
  6
  4
  2
  1
  1
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Eastman Chemical Company (Eastman) is an advanced materials and specialty additives company. The Company's segments include Additives & Functional Products (AFP), Advanced Materials (AM), Chemical Intermediates (CI), and Fibers. In the AFP segment, it manufactures chemicals for products in the coatings, tires, consumables, building and construction, industrial applications, including solar energy markets, animal nutrition, care chemicals, crop protection, and energy markets. In the AM segment, it produces and markets its polymers, films, and plastics with differentiated performance properties for end uses in transportation, consumables, building and construction, durable goods, and health and wellness products. The CI segment leverages large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support its specialty operating segments. Its product lines in Fibers segment include Acetate Tow, Acetate Yarn and Acetyl Chemical Products.

FINANCIAL RATIOS  of  Eastman Chemical (EMN)

Valuation Ratios
P/E Ratio 16.8
Price to Sales 1.6
Price to Book 3.2
Price to Tangible Book
Price to Cash Flow 10.3
Price to Free Cash Flow 18.9
Growth Rates
Sales Growth Rate -6.6%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -4%
Cap. Spend. - 3 Yr. Gr. Rate 5.1%
Financial Strength
Quick Ratio 1
Current Ratio 0
LT Debt to Equity 139.3%
Total Debt to Equity 145.5%
Interest Coverage 5
Management Effectiveness
Return On Assets 7%
Ret/ On Assets - 3 Yr. Avg. 6.7%
Return On Total Capital 7.7%
Ret/ On T. Cap. - 3 Yr. Avg. 7.8%
Return On Equity 20.2%
Return On Equity - 3 Yr. Avg. 21.2%
Asset Turnover 0.6
Profitability Ratios
Gross Margin 26.1%
Gross Margin - 3 Yr. Avg. 25.4%
EBITDA Margin 21.2%
EBITDA Margin - 3 Yr. Avg. 19.5%
Operating Margin 14.4%
Oper. Margin - 3 Yr. Avg. 13.7%
Pre-Tax Margin 11.6%
Pre-Tax Margin - 3 Yr. Avg. 11.2%
Net Profit Margin 9.5%
Net Profit Margin - 3 Yr. Avg. 8.7%
Effective Tax Rate 18.1%
Eff/ Tax Rate - 3 Yr. Avg. 22.1%
Payout Ratio 31.9%

EMN stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the EMN stock intrinsic value calculation we used $9008 million for the last fiscal year's total revenue generated by Eastman Chemical. The default revenue input number comes from 2016 income statement of Eastman Chemical. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our EMN stock valuation model: a) initial revenue growth rate of 7.8% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.4%, whose default value for EMN is calculated based on our internal credit rating of Eastman Chemical, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Eastman Chemical.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of EMN stock the variable cost ratio is equal to 85.7%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for EMN stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 4.1% for Eastman Chemical.

Corporate tax rate of 27% is the nominal tax rate for Eastman Chemical. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the EMN stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for EMN are equal to 86.2%.

Life of production assets of 21.1 years is the average useful life of capital assets used in Eastman Chemical operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for EMN is equal to 13%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $4532 million for Eastman Chemical - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 144.97 million for Eastman Chemical is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Eastman Chemical at the current share price and the inputted number of shares is $14.2 billion.

RELATED COMPANIES Price Int.Val. Rating
CE Celanese Serie 111.12 30.12  str.sell
LYB LyondellBasell 118.94 344.40  str.buy
WLK Westlake Chemi 109.86 471.19  str.buy
KRA Kraton 50.89 40.25  hold
TSE Trinseo 79.60 70.95  hold
HUN Huntsman 34.74 31.79  hold

COMPANY NEWS

▶ Praxairs Stock Performance since Its 3Q17 Earnings   [Jan-18-18 10:01AM  Market Realist]
▶ Eastman Chemical Sees RS Rating Improve To 73   [Jan-04-18 03:00AM  Investor's Business Daily]
▶ Whats Eastman Chemicals Short Interest?   [Dec-21-17 10:30AM  Market Realist]
▶ Stocks With Rising Relative Strength: Eastman Chemical   [03:00AM  Investor's Business Daily]
▶ What Analysts Recommend for Eastman Chemical   [Dec-20-17 10:40AM  Market Realist]
▶ Huntsman Continues to Trade at a Premium Compared to EMN   [Dec-14-17 12:37PM  Market Realist]
▶ Eastman Chemical Gets Relative Strength Rating Upgrade   [Dec-01-17 03:00AM  Investor's Business Daily]
▶ Eastman Chemicals Tritan Associate with RELAX Expands   [Nov-27-17 10:47AM  Market Realist]
▶ Media Advisory Issued November 20, 2017   [Nov-20-17 02:09PM  GlobeNewswire]
▶ Eastman Chemical Signs New Deal with Sudeep Plastics   [Oct-30-17 05:02PM  Market Realist]
▶ Eastman Chemical tops Street 3Q forecasts   [Oct-26-17 05:21PM  Associated Press]
▶ Eastman Chemical Provides Its Fiscal Guidance   [Oct-16-17 08:29AM  Market Realist]
▶ Whats Celaneses Valuation ahead of 3Q17 Earnings?   [Oct-12-17 09:09AM  Market Realist]
▶ Eastman Chemical: No health impact from plant explosions   [Oct-05-17 01:01PM  Associated Press]
▶ Why Celanese Trades at Premium Compared to Its Peers   [Oct-02-17 07:41AM  Market Realist]
▶ Eastman Chemical Rose to 3-Year Highs   [07:41AM  Market Realist]
▶ Eastman Chemical topping IQ100 leaders   [Sep-28-17 02:50PM  CNBC Videos]
▶ Eastman Chemical Hikes Prices of Amines   [Sep-26-17 07:40AM  Market Realist]
▶ Whats Driving Eastman Chemicals Stock Price?   [Sep-19-17 09:07AM  Market Realist]
▶ PolyOnes Valuation Compared to Its Peers   [08:07AM  Market Realist]
▶ What Eastman Chemicals Valuations Suggest   [07:37AM  Market Realist]
▶ Eastman Chemical Hikes the Prices of Esters and Alcohols   [Sep-18-17 01:21PM  Market Realist]
▶ What Analysts Recommend for Eastman Chemical   [10:38AM  Market Realist]
▶ How Huntsmans Valuation Compares   [09:36AM  Market Realist]
▶ Eastman Chemical Hiked Acids and Aldehydes Prices   [Sep-12-17 07:44AM  Market Realist]
Financial statements of EMN
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.